Development of a potential vaccine against dengue and chikungunya virus co-infection using immunoinformatics and structural evaluation. [PDF]
Ullah S +14 more
europepmc +1 more source
Cocoa by-products extracts suppress viral replication and oxidative stress in chikungunya virus-infected cells. [PDF]
Morantes SJ +6 more
europepmc +1 more source
Impact of climate change on the global circulation of chikungunya virus: current evidence, future projections, and adaptation strategies. [PDF]
Wang C +6 more
europepmc +1 more source
Development of Covalent Inhibitors of Chikungunya Virus nsP2 Cysteine Protease Enabled by Direct-to-Biology Synthesis and Screening. [PDF]
Cai Z +8 more
europepmc +1 more source
Chikungunya virus TF inhibits SNX27-mediated endocytic recycling of GLUT1. [PDF]
Wang S, Zhang D, Zhang L.
europepmc +1 more source
Viral kinetics of the Chikungunya virus ESCA-MAL lineage during the 2025 Guangdong outbreak. [PDF]
He Y +8 more
europepmc +1 more source
Pathogenesis of Chronic Arthritis Due to Chikungunya Virus and Advances in Vaccine Development. [PDF]
Ma M, Li L, Sun H, Zhang X.
europepmc +1 more source
Luciferase unleashed: Lighting the path to vaccine approval using a novel high-throughput chikungunya virus neutralization assay. [PDF]
Mendy J +8 more
europepmc +1 more source
Chikungunya Virus: Unveiling Its Global Impact (2002-2024). [PDF]
Issrani R +7 more
europepmc +1 more source
Overview of Chikungunya Virus Pathogenesis, Genome Variation, Epidemiology, and Control. [PDF]
Hamrahjoo M +4 more
europepmc +1 more source

